Kura Oncology KURA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $39.08M-73.8% | $149.1M+56.5% | $95.29M+16.3% | $81.95M+59.8% | $51.27M-77.2% | ||
| $541.74M+4.6% | $518.14M+14.0% | $454.38M-17.2% | $548.78M-9.6% | $606.92M+20.7% | ||
| $9.35M+6.2% | $8.8M-75.5% | $35.94M+686% | $4.57M-90.6% | $48.75M+2,266% | ||
| $843K+104% | $413K+300% | $103.25K0.0% | $103.25K0.0% | $103.25K— | ||
| $32.77M+1.7% | $32.21M-8.1% | $35.06M+41.5% | $24.77M+43.5% | $17.26M+12.3% | ||
| $623.78M-12.0% | $708.66M+14.2% | $620.66M-6.0% | $660.08M-8.9% | $724.2M-2.8% | ||
| $7.61M-3.1% | $7.86M+6.2% | $7.4M+89.1% | $3.91M+66.6% | $2.35M+39.6% | ||
| $7.17M-1.9% | $7.3M-3.1% | $7.54M-4.1% | $7.86M-3.4% | $8.14M+40.3% | ||
| $13.99M-3.8% | $14.54M+5.5% | $13.78M+30.3% | $10.57M+16.5% | $9.08M+15.7% | ||
| $652.55M-11.6% | $738.36M+13.7% | $649.38M-4.8% | $682.43M-8.2% | $743.76M-2.2% | ||
| $7.04M+40.4% | $5.02M-92.5% | $66.79M+26.2% | $52.93M+17.4% | $45.09M+2,970% | ||
| $45.47M-26.3% | $61.7M— | —— | —— | —— | ||
| $47.7M-2.6% | $48.98M+0.5% | $48.75M-1.4% | $49.44M+21.0% | $40.85M+68.3% | ||
| —— | $0-100% | $4.34M+39.4% | $3.11M+62.0% | $1.92M-26.3% | ||
| $1.28M+0.5% | $1.28M-10.6% | $1.43M-15.7% | $1.7M-11.0% | $1.91M+1.3% | ||
| $416.75M-1.9% | $424.91M+58.0% | $268.85M+6.5% | $252.51M-7.1% | $271.93M+7.1% | ||
| $101.5M-13.2% | $116.97M-3.6% | $121.3M+13.2% | $107.17M+19.4% | $89.77M+14.0% | ||
| $9.75M+0.4% | $9.71M+82.0% | $5.34M-18.0% | $6.51M-14.9% | $7.65M+10.6% | ||
| $13.24M+39.8% | $9.47M+13.2% | $8.36M+2.6% | $8.16M+3.5% | $7.88M+51.8% | ||
| $14.52M+35.2% | $10.75M+9.7% | $9.79M-0.6% | $9.85M+0.7% | $9.78M+38.4% | ||
| $3.44M+8.6% | $3.17M+6.2% | $2.98M+14.9% | $2.6M+21.3% | $2.14M+19.2% | ||
| $544.67M-3.5% | $564.23M+38.7% | $406.84M+7.9% | $376.94M-0.6% | $379.36M+9.5% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K+12.5% | $8K0.0% | ||
| $1.36B+0.6% | $1.35B+0.9% | $1.33B+0.8% | $1.32B+0.6% | $1.32B+0.6% | ||
| -$1.25B-6.2% | -$1.17B-7.4% | -$1.09B-7.3% | -$1.02B-6.9% | -$952.85M-6.4% | ||
| -$380K-137% | $1.02M+11.5% | $918K+29.1% | $711K-27.0% | $974K+27.5% | ||
| $107.88M-38.0% | $174.14M-28.2% | $242.54M-20.6% | $305.49M-16.2% | $364.41M-11.9% | ||
| $652.55M-11.6% | $738.36M+13.7% | $649.38M-4.8% | $682.43M-8.2% | $743.76M-2.2% | ||
| $541.74M+4.6% | $518.14M+14.0% | $454.38M-17.2% | $548.78M-9.6% | $606.92M+20.7% | ||
| $13.99M-3.8% | $14.54M+5.5% | $13.78M+30.3% | $10.57M+16.5% | $9.08M+15.7% | ||
| $7.17M-1.9% | $7.3M-3.1% | $7.54M-4.1% | $7.86M-3.4% | $8.14M+40.3% | ||
| $7.17M-1.9% | $7.3M-3.1% | $7.54M-4.1% | $7.86M-3.4% | $8.14M+40.3% | ||
| $13.99M-3.8% | $14.54M+5.5% | $13.78M+30.3% | $10.57M+16.5% | $9.08M+15.7% | ||
| $7.17M-1.9% | $7.3M-3.1% | $7.54M-4.1% | $7.86M-3.4% | $8.14M+40.3% | ||
| $13.99M-3.8% | $14.54M+5.5% | $13.78M+30.3% | $10.57M+16.5% | $9.08M+15.7% | ||
| $416.75M-1.9% | $424.91M+58.0% | $268.85M+6.5% | $252.51M-7.1% | $271.93M+7.1% | ||
| $416.75M-1.9% | $424.91M+58.0% | $268.85M+6.5% | $252.51M-7.1% | $271.93M+7.1% | ||
| $45.47M-26.3% | $61.7M— | —— | —— | —— | ||
| $416.75M-1.9% | $424.91M+58.0% | $268.85M+6.5% | $252.51M-7.1% | $271.93M+7.1% | ||
| $24.27M+18.7% | $20.46M+5.1% | $19.47M0.0% | $19.47M+0.6% | $19.35M+16.6% | ||
| -$380K-137% | $1.02M+11.5% | $918K— | —— | —— | ||
| $1.36B+0.6% | $1.35B+0.9% | $1.33B+0.8% | $1.32B+0.6% | $1.32B+0.6% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K+12.5% | $8K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kura Oncology's total assets?
- Kura Oncology (KURA) holds $652.6M in total assets, down 12.3% year over year.
- How much debt does Kura Oncology have?
- Kura Oncology carries $24.3M in total debt against $107.9M of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does Kura Oncology have?
- Kura Oncology holds $39.1M in cash and equivalents.
- Can Kura Oncology cover its short-term obligations?
- Its current ratio is 6.15 — current assets exceed current liabilities.
- Where does Kura Oncology's balance sheet data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
